Nexeon Medsystems Inc
OTC:NXNN
Fundamental Analysis
Want a deep‑dive on Nexeon Medsystems Inc?
Request it below and we’ll move it up the queue.

Revenue & Expenses Breakdown
Nexeon Medsystems Inc
Balance Sheet Decomposition
Nexeon Medsystems Inc
Current Assets | 5.2m |
Cash & Short-Term Investments | 125.6k |
Receivables | 2.5m |
Other Current Assets | 2.5m |
Non-Current Assets | 13.4m |
Long-Term Investments | 112.1k |
PP&E | 3.4m |
Intangibles | 9.8m |
Other Non-Current Assets | -100 |
Free Cash Flow Analysis
Nexeon Medsystems Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Nexeon Medsystems Inc
Revenue
|
9.8m
USD
|
Cost of Revenue
|
-6.8m
USD
|
Gross Profit
|
3m
USD
|
Operating Expenses
|
-8.7m
USD
|
Operating Income
|
-5.7m
USD
|
Other Expenses
|
4m
USD
|
Net Income
|
-1.7m
USD
|
NXNN Profitability Score
Profitability Due Diligence
Nexeon Medsystems Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Nexeon Medsystems Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
NXNN Solvency Score
Solvency Due Diligence
Nexeon Medsystems Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
Nexeon Medsystems Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NXNN Price Targets Summary
Nexeon Medsystems Inc
Dividends
Current shareholder yield for NXNN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?